Amicus Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Amicus Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Amicus Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Amicus Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Amicus Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4285902A2 | Application | Augmentierte alpha-glucosidase zur behandlung von morbus pompe | C12Y302/0102; A61K31/05; A61K31/445; A61K38/47 | December 06, 2023 |
| EP4245366A9 | Application | Migalastat zur behandlung von nierenbeeinträchtigten patienten mit morbus fabry | C12Y302/01022; A61K31/445; A61P13/12 | December 06, 2023 |
| EP4285990A2 | Application | Verfahren zur behandlung von morbus fabry bei patienten mit einer mutation in dem gla-gen | C12Q1/6883; C12Q2600/156; A61K31/445; A61K31/7004; A61P3/00; A61P43/00 | December 06, 2023 |
| EP4285991A2 | Application | Verfahren zur behandlung von morbus fabry bei patienten mit einer mutation in dem gla-gen | C12Q1/6883; C12Q2600/156; A61K31/445; A61K31/7004; A61P3/00; A61P43/00 | December 06, 2023 |
| US11833164B2 | Grant | Methods of treating fabry disease in patients having a mutation in the gla gene | C12Q1/6883; C12Q2600/106; C12Q2600/156; A61K31/7008; G16B20/20; G16H50/20 | December 05, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer